These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26696199)

  • 1. [Evaluation of long-term effect for house dust mite subcutaneous immunotherapy for patients with allergic rhinitis].
    Song W; Lin X; Chai R
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):632-5. PubMed ID: 26696199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
    Huang HH; Xu C; Liu L; Chai RN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect evaluation of allergen specific immunotherapy in patients with allergic rhinitis and asthma].
    Song W; Xie H; Chai R; Lin X; Song L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 29(7):629-32. PubMed ID: 26201190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the efficacy and safety of standardized dust mite allergen specific immunotherapy to children with allergic asthma].
    Song W; Lin X; Xie H; Chai R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1193-6. PubMed ID: 24617000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy evaluation of standardized dust mite allergen specific immunotherapy to patients of allergic rhinitis].
    Song W; Lin X; Chai R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(5):300-2. PubMed ID: 25185281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis].
    You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014
    [No Abstract]   [Full Text] [Related]  

  • 8. Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Asian Pac J Allergy Immunol; 2013 Sep; 31(3):233-41. PubMed ID: 24053706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and adverse reactions to subcutaneous immunotherapy in children with allergic rhinitis/asthma.
    Duman Senol H; Topyildiz E; Ekici B; Gulen F; Demir E
    Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111292. PubMed ID: 36007303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic efficacy of 3-year subcutaneous immunotherapy in asthmatic children allergic to mite].
    Li L; Hui Y; Qian J; Guo Y; Zhang XL; Zhang XJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 May; 15(5):368-71. PubMed ID: 23676940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis].
    Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of allergen-specific subcutaneous immunotherapy for house dust mite induced allergic rhinitis.
    Sahin E; Dizdar D; Dinc ME; Cirik AA
    J Laryngol Otol; 2017 Nov; 131(11):997-1001. PubMed ID: 29037263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of specific immunotherapy on house dust mite-induced allergic rhinitis in China.
    Peng H; Li CW; Lin ZB; Li TY
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):40-6. PubMed ID: 23569202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
    Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
    [No Abstract]   [Full Text] [Related]  

  • 19. Semi-depot house-dust mite allergen extract for Chinese with allergic rhinitis and asthma.
    Li X; Wang X; Lin X; Xu G; Tao Z; Jiang W; Cheng L; Guo Y; Lai H; Shen K
    Am J Rhinol Allergy; 2016 May; 30(3):201-8. PubMed ID: 27216351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma.
    Zhang P; Jia Y; Jing Z; Huang J; Wu H; Sun X
    Pulm Pharmacol Ther; 2023 Feb; 78():102187. PubMed ID: 36603742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.